Ocuphire Pharma (OCUP) Revenue & Revenue Breakdown
Ocuphire Pharma Revenue Highlights
Latest Revenue (Y)
$19.05M
Ocuphire Pharma Revenue by Period
Ocuphire Pharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $19.05M | -52.20% |
| 2022-12-31 | $39.85M | 6665.70% |
| 2021-12-31 | $589.00K | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-12-31 | - | -100.00% |
| 2005-12-31 | $190.61K | - |
Ocuphire Pharma generated $19.05M in revenue during NA 2023, up -52.20% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Ocuphire Pharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $1.71M | 1.18% |
| 2023-12-31 | $1.69M | -85.83% |
| 2023-09-30 | $11.94M | 224.85% |
| 2023-06-30 | $3.67M | 110.06% |
| 2023-03-31 | $1.75M | -95.61% |
| 2022-12-31 | $39.85M | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $-589.00K | -220.45% |
| 2021-09-30 | $489.00K | 389.00% |
| 2021-06-30 | $100.00K | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | -100.00% |
| 2020-03-31 | $1.15M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-09-30 | - | - |
Ocuphire Pharma generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Ocuphire Pharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RIGL | Rigel Pharmaceuticals | $116.88M | $36.84M |
| FBIO | Fortress Biotech | $59.66M | $13.03M |
| EYPT | EyePoint Pharmaceuticals | $46.02M | $9.48M |
| OCUP | Ocuphire Pharma | $19.05M | - |
| CKPT | Checkpoint Therapeutics | $103.00K | $41.00K |
| EYEN | Eyenovia | $3.79K | $4.99K |
| MBIO | Mustang Bio | - | - |
| RVPH | Reviva Pharmaceuticals | - | - |
| CGTX | Cognition Therapeutics | - | - |
| KOD | Kodiak Sciences | - | - |
| SLS | SELLAS Life Sciences Group | - | - |
| RNAZ | TransCode Therapeutics | - | - |
OCUP Revenue FAQ
What is Ocuphire Pharma’s yearly revenue?
Ocuphire Pharma's yearly revenue for 2023 was $19.05M, representing a decrease of -52.20% compared to 2022. The company's yearly revenue for 2022 was $39.85M, representing an increase of 6665.70% compared to 2021. OCUP's yearly revenue for 2021 was $589K, representing an increase of 100.00% compared to 2020.
What is Ocuphire Pharma’s quarterly revenue?
Ocuphire Pharma's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.71M, a 1.18% increase from the previous quarter (Q4 2023), and a -2.17% decrease year-over-year (Q1 2023). OCUP's quarterly revenue for Q4 2023 was $1.69M, a -85.83% decrease from the previous quarter (Q3 2023), and a -95.76% decrease year-over-year (Q4 2022).
What is Ocuphire Pharma’s revenue growth rate?
Ocuphire Pharma's revenue growth rate for the last 3 years (2021-2023) was 3134.13%, and for the last 5 years (2019-2023) was 0%.